Business Description

STERIS plc is a global medical technology company specializing in infection prevention, sterilization, and surgical products. The company provides contract sterilization services, capital equipment such as sterilizers and surgical tables, and consumable products to hospitals, pharmaceutical manufacturers, and medical device makers. While legally domiciled in Ireland, STERIS maintains its operational headquarters in Mentor, Ohio.

Everything on STERIS plc

Revenue (FY2026) $5.94B
YoY growth +8.7%
Operating margin 18.6%
Direction Expanding
Gross margin 44.2%
Net margin 13.2%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Dr. Esther M. Alegria — Independent Director; Chair of the Compliance and Technology Committee View full profile ↗ Pierre Boulud — Independent Director View full profile ↗ Daniel A. Carestio — President and Chief Executive Officer; Director View full profile ↗ Cynthia L. Feldmann — Independent Director; Chair of the Nominating and Governance Committee View full profile ↗ Christopher S. Holland — Independent Director; Chair of the Compensation and Organization Development Committee View full profile ↗ Paul E. Martin — Independent Director View full profile ↗ Dr. Nirav R. Shah — Independent Director View full profile ↗ Louis A. Shapiro — Independent Director View full profile ↗ Dr. Mohsen M. Sohi — Chairman of the Board (Independent Director) View full profile ↗ Karen L. Burton — Senior Vice President and Chief Financial Officer View full profile ↗ Mary Clare Fraser — Senior Vice President and Chief Human Resources Officer View full profile ↗ Kenneth E. Kohler — Senior Vice President and General Manager, AST View full profile ↗ Julia K. Madsen — Senior Vice President and General Manager, Life Sciences View full profile ↗ Cary L. Majors — Senior Vice President and President, Healthcare View full profile ↗ Lindsey M. McGowan — Chief Compliance and Quality Officer View full profile ↗ Renato G. Tamaro — Vice President and Corporate Treasurer View full profile ↗ J. Adam Zangerle — Senior Vice President, General Counsel, and Company Secretary View full profile ↗ Michael J. Tokich — Senior Financial Advisor (former Senior Vice President and Chief Financial Officer) View full profile ↗

Share Repurchase Program

Total authorized
$500.0 million (Outgoing Repurchase Program, authorized May 3, 2023); superseded by a new $1.0 billion program authorized May 5, 2026 (subsequent event)
Remaining
$75.0 million remaining under the Outgoing Repurchase Program as of March 31, 2026 (fiscal 2026 repurchases totaled $225.0 million / 0.9 million shares)

Named Competitors

3MBaxterBoston ScientificBelimedEcolabFortiveGetingeKarl StorzOlympusRuhofSteelCoStrykerSkytronWassenburgB. BraunCrothallPentaxSterigenicsContecFedegariStilmas +9 more

Customer Concentration

For the year ended March 31, 2026, no single Customer represented more than 10% of the total revenues of the Healthcare, AST, or Life Sciences segments.

Recent SEC Filings

2026-08-06 Shareholder vote results View filing ↗
2026-08-05 Reported quarterly results (+1 more) View filing ↗
2026-05-11 Reported quarterly results View filing ↗
2026-05-07 Leadership change (directors/officers) (+1 more) View filing ↗
2026-04-06 Leadership change (directors/officers) View filing ↗
2026-02-04 Reported quarterly results View filing ↗
2025-11-05 Reported quarterly results View filing ↗
2025-08-06 Reported quarterly results (+2 more) View filing ↗
2025-07-03 Leadership change (directors/officers) View filing ↗
2025-05-14 Reported quarterly results View filing ↗
2025-03-03 Other event View filing ↗
2025-02-05 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.